![Amy Conrad](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Amy Conrad active positions
Companies | Position | Start | End |
---|---|---|---|
TYRA BIOSCIENCES, INC. | Investor Relations Contact | - | - |
Public Communications Contact | - | - | |
Juniper Point, Inc. | Chief Executive Officer | - | - |
Career history of Amy Conrad
Former positions of Amy Conrad
Companies | Position | Start | End |
---|---|---|---|
REGULUS THERAPEUTICS INC. | Investor Relations Contact | - | 31/12/2015 |
Public Communications Contact | - | 31/12/2015 | |
BIONANO GENOMICS, INC. | Investor Relations Contact | - | - |
Anadys Pharmaceuticals, Inc.
![]() Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Investor Relations Contact | 22/08/2011 | - |
Public Communications Contact | 25/05/2010 | - |
Statistics
International
United States | 6 |
Operational
Investor Relations Contact | 4 |
Public Communications Contact | 3 |
Chief Executive Officer | 1 |
Sectoral
Health Technology | 5 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
REGULUS THERAPEUTICS INC. | Health Technology |
BIONANO GENOMICS, INC. | Health Technology |
TYRA BIOSCIENCES, INC. | Health Technology |
Private companies | 2 |
---|---|
Anadys Pharmaceuticals, Inc.
![]() Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Health Technology |
Juniper Point, Inc. |
- Stock Market
- Insiders
- Amy Conrad
- Experience